Lu Yao

机构：Peking University, Peking University Cancer Hospital, Nanjing Brain Hospital · ORCID：0000-0002-6430-8712

发表论文 85 篇 · 总被引 2074 次 · h-index 21

代表论文

• BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers (2022 · Journal of Clinical Oncology · 被引 32)
• Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study (2024 · European Journal of Cancer · 被引 21)
• Signal-induced enhancer activation requires Ku70 to read topoisomerase1–DNA covalent complexes (2023 · Nature Structural & Molecular Biology · 被引 17)
• The impact of virtual reality applied in nurse education on students' clinical thinking: A systematic review (2024 · Nurse Education Today · 被引 15)
• Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype (2022 · Breast Cancer Research and Treatment · 被引 15)
• Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients (2022 · npj Breast Cancer · 被引 10)